| Financial Year |
March 31 2023 |
| Monetary Funds |
1,539,112,925.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
280,652,858.62 |
| Advances to Suppliers |
36,287,867.01 |
| Other Receivables |
9,211,960.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
360,000.00 |
| Inventories |
240,927,412.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,807,071.56 |
| Total Current Assets |
2,148,547,119.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
24,428,682.53 |
| Fixed Assetes |
592,764,232.49 |
| Under-construction Projects |
304,204,742.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
265,064,407.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
82,145,826.46 |
| Deferred Income Tax Assets |
35,198,991.37 |
| Other Non-Current Assets |
5,607,285.57 |
| Sub-Total of Non-Current Assets |
1,335,108,796.71 |
| Total Assets |
3,483,655,915.88 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
944,862,154.98 |
| Accounts Payable |
894,555,169.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,830,177.79 |
| Taxes Payable |
25,315,757.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
244,322,075.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,531,683.48 |
| Other Current Liabilities |
4,165,469.50 |
| Sub-Total of Current Liabilities |
2,267,141,816.20 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
756,644.07 |
| Deferred Income Tax Liabilities |
1,659,675.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,962,078.06 |
| Total Liabilities |
2,282,103,894.26 |
| Paid-In Capital(Or Share Stock) |
204,000,000.00 |
| Capital Surplus |
230,318,566.66 |
| Surplus Reserve |
88,798,055.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
679,768,752.17 |
| Minority Stockholder's Interest |
2,511,512.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,199,040,509.45 |
| Owner's Equity（Stockholder's Equity） |
1,201,552,021.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,483,655,915.88 |
